Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies targeting unmet medical needs in humans, with a focus on osteoarthritis (OA), neuropathic pain, and dermatology. Its stem cell technologies use mesenchymal stem cells (MSCs) from adipose tissue.